{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:24:03Z","timestamp":1791343443286,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1803,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.exphem.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T16:15:28Z","timestamp":1493223328000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models"],"prefix":"10.1016","volume":"51","author":[{"given":"Marco","family":"Carretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bauke","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Jaques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost D.","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.J.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Jacob","family":"Schuringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.04.008_bib1","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chain(null) mice","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.exphem.2017.04.008_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccell.2016.06.008","article-title":"The public repository of xenografts enables discovery and randomized phase II-like trials in mice","volume":"30","author":"Townsend","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/leu.2011.250","article-title":"Frequency of leukemic initiating cells does not depend on the xenotransplantation model used","volume":"26","author":"Vargaftig","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib6","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/leu.2009.143","article-title":"A robust xenotransplantation model for acute myeloid leukemia","volume":"23","author":"Sanchez","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/leu.2016.166","article-title":"Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.leu.2403222","article-title":"NOD\/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration","volume":"18","author":"Nicolini","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib9","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.1203543","article-title":"Establishment of a human allergy model using human IL-3\/GM-CSF-transgenic NOG mice","volume":"191","author":"Ito","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2017.04.008_bib10","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2011-05-353243","article-title":"Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rgamma null mice is enhanced by transgenic expression of membrane-bound human SCF","volume":"119","author":"Brehm","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2017.04.008_bib14","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1073\/pnas.1019524108","article-title":"Human thrombopoietin knockin mice efficiently support human hematopoiesis in\u00a0vivo","volume":"108","author":"Rongvaux","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.04.008_bib15","doi-asserted-by":"crossref","first-page":"13218","DOI":"10.1073\/pnas.1109769108","article-title":"Transgenic expression of human signal regulatory protein alpha in Rag2-\/-gamma(c)-\/- mice improves engraftment of human hematopoietic cells in humanized mice","volume":"108","author":"Strowig","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.04.008_bib16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1073\/pnas.1019682108","article-title":"Human IL-3\/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung","volume":"108","author":"Willinger","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.04.008_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.it.2011.04.005","article-title":"Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement","volume":"32","author":"Willinger","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2017.04.008_bib18","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2014-11-570218","article-title":"Xenograft models for normal and malignant stem cells","volume":"125","author":"Goyama","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3324\/haematol.2014.115212","article-title":"Humanized hemato-lymphoid system mice","volume":"101","author":"Theocharides","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2017.04.008_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib21","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/leu.2016.108","article-title":"Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model","volume":"30","author":"Sontakke","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1073\/pnas.95.3.1195","article-title":"Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin","volume":"95","author":"Kimura","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.04.008_bib23","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4161\/cc.10.10.15619","article-title":"Thrombopoietin and hematopoietic stem cells","volume":"10","author":"de Graaf","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2017.04.008_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","article-title":"Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche","volume":"118","author":"Arai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.008_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2017.04.008_bib28","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1182\/blood-2012-03-414920","article-title":"Reconstructing the human hematopoietic niche in immunodeficient mice: Opportunities for studying primary multiple myeloma","volume":"120","author":"Groen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood-2009-03-209734","article-title":"Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis","volume":"114","author":"Rizo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20041024","article-title":"Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation","volume":"200","author":"Schuringa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2017.04.008_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/scd.2006.0660","article-title":"Identification of cord blood-derived mesenchymal stem\/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles","volume":"16","author":"Markov","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2017.04.008_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-59745-418-6_14","article-title":"Ex\u00a0vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells","volume":"538","author":"Schuringa","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2017.04.008_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-1133-2_13","article-title":"Ex\u00a0vivo assays to study self-renewal, long-term expansion, and leukemic transformation of genetically modified human hematopoietic and patient-derived leukemic stem cells","volume":"1185","author":"Sontakke","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2017.04.008_bib34","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.exphem.2007.07.001","article-title":"Establishing long-term cultures with self-renewing acute myeloid leukemia stem\/progenitor cells","volume":"35","author":"van Gosliga","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2017.04.008_bib35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/leu.2012.343","article-title":"MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny","volume":"27","author":"Horton","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.008_bib36","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1182\/blood-2011-11-389957","article-title":"Human extramedullary bone marrow in mice: A novel in\u00a0vivo model of genetically controlled hematopoietic microenvironment","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.008_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.4103","article-title":"A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells","volume":"22","author":"Reinisch","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.04.008_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jim-2016-000076","article-title":"Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia","volume":"64","author":"Francis","year":"2016","journal-title":"J Investig Med"},{"key":"10.1016\/j.exphem.2017.04.008_bib39","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/eji.201646307","article-title":"TSLP or IL-7 provide an IL-7Ralpha signal that is critical for human B lymphopoiesis","volume":"46","author":"Milford","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2017.04.008_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2015.125336","article-title":"A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis","volume":"101","author":"Francis","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2017.04.008_bib41","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.1220108110","article-title":"Engineering of a functional bone organ through endochondral ossification","volume":"110","author":"Scotti","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:27:01Z","timestamp":1654925221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X17301406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":41,"alternative-id":["S0301472X17301406"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}